Synonym
AZ7976; AZ-7976; AZ 7976
IUPAC/Chemical Name
(1S,4s)-4-(2-fluoro-5-(((1S,2R,3S,4R)-3-((4-fluoro-3-(pentafluoro-l6-sulfaneyl)phenyl)carbamoyl)bicyclo[2.2.1]heptan-2-yl)carbamoyl)-4-methoxyphenoxy)-1-methylcyclohexane-1-carboxylic acid
InChi Key
CDRWWKJURUZOFS-XOGKYOQESA-N
InChi Code
InChI=1S/C30H33F7N2O6S/c1-30(29(42)43)9-7-18(8-10-30)45-23-13-19(22(44-2)14-21(23)32)27(40)39-26-16-4-3-15(11-16)25(26)28(41)38-17-5-6-20(31)24(12-17)46(33,34,35,36)37/h5-6,12-16,18,25-26H,3-4,7-11H2,1-2H3,(H,38,41)(H,39,40)(H,42,43)/t15-,16+,18-,25+,26-,30+/m1/s1
SMILES Code
C[C@]1(C(O)=O)CC[C@@H](OC2=C(F)C=C(OC)C(C(N[C@@H]3[C@H](C4)CC[C@H]4[C@@H]3C(NC5=CC=C(F)C(S(F)(F)(F)(F)F)=C5)=O)=O)=C2)CC1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
682.65
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Granberg KL, Sakamaki S, Fuchigami R, Niwa Y, Fujio M, Kato H, Bergström F,
Larsson N, Persson M, Villar IC, Fujita T, Sugikawa E, Althage M, Yano N,
Yokoyama Y, Kimura J, Lal M, Mochida H. Identification of Novel Series of Potent
and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists. J Med Chem.
2024 Mar 19. doi: 10.1021/acs.jmedchem.3c02183. Epub ahead of print. PMID:
38502780.
2: Granberg KL, Sakamaki S, Larsson N, Bergström F, Fuchigami R, Niwa Y, Ryberg
E, Backmark A, Kato H, Miyazaki S, Iguchi K, Sakamoto T, Persson M, Idei A,
Prieto Garcia L, Villar IC, Gradén H, Bergonzini G, Arvidsson T, Fujita T,
Althage M, Ulander J, Kimura J, Yoneda H, Fjellström O, Mochida H, Lal M.
Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1
Agonist for Treatment of Heart Failure. J Med Chem. 2024 Mar 19. doi:
10.1021/acs.jmedchem.3c02184. Epub ahead of print. PMID: 38502782.